thiophenes has been researched along with cardiovascular agents in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Engel, J; Heese, J; Kleemann, A | 1 |
Lüscher, TF; Spieker, LE | 1 |
Laustsen, G; Wimmett, L | 1 |
Clark, L; Crawford, FA; Finklea, L; Harrell, A; Hilton, EJ; Ikonomidis, JS; Leonardi, A; Payne, K; Reeves, S; Spinale, FG; Stroud, RE | 1 |
Cohen, M; Giugliano, R; Granger, CB; Gurbel, PA; Hoekstra, J; Hollander, JE; Manoukian, SV; Pollack, CV; Saucedo, JF | 1 |
Adams, S; Berna, MJ; Bull, CM; Chiang, AY; Cockman, MD; Credille, KM; Engle, SK; Liu, H; Lu, Y; Pritt, ML; Rothstein, EC; Schultze, AE; Solter, PF; Watson, DE | 1 |
Silber, S | 1 |
Alves, RO; Barreiro, EJ; Braga, RC; de Oliveira, V; Fraga, CA; Persiano, CB; Tôrres, AC | 1 |
Biswal, S | 1 |
Bajaj, M; Birnbaum, Y; Chen, H; Nanhwan, MK; Qian, J; Ye, Y | 1 |
Dopona, EPB; Furukawa, LNS; Heimann, JC; Oliveira, IB; Rocha, VF | 1 |
3 review(s) available for thiophenes and cardiovascular agents
Article | Year |
---|---|
Will endothelin receptor antagonists have a role in heart failure?
Topics: Animals; Bosentan; Cardiovascular Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Humans; Isoxazoles; Oligopeptides; Peptides, Cyclic; Phenylpropionates; Piperidines; Pyridines; Pyrimidines; Sulfonamides; Tetrazoles; Thiophenes; Treatment Outcome | 2003 |
2004 drug approval highlights: FDA update.
Topics: Administration, Cutaneous; Amlodipine; Anti-Bacterial Agents; Antidepressive Agents; Bronchodilator Agents; Cardiovascular Agents; Drug Approval; Drug Combinations; Duloxetine Hydrochloride; Eplerenone; Estradiol; Excitatory Amino Acid Antagonists; Female; Gastrointestinal Agents; Heptanoic Acids; Humans; Ketolides; Male; Memantine; Osteoporosis, Postmenopausal; Pyrroles; Rifamycins; Rifaximin; Scopolamine Derivatives; Spironolactone; Thiophenes; Tiotropium Bromide; United States | 2005 |
Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: an evidence-based review of clinical trial results and treatment guidelines: report on a roundtable discussion.
Topics: Acute Coronary Syndrome; Algorithms; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cardiovascular Agents; Clinical Trials as Topic; Clopidogrel; Emergency Treatment; Evidence-Based Medicine; Fibrinolytic Agents; Hirudins; Humans; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Hemorrhage; Practice Guidelines as Topic; Prasugrel Hydrochloride; Recombinant Proteins; Risk Assessment; Stents; Thiophenes; Thrombosis; Ticlopidine | 2008 |
1 trial(s) available for thiophenes and cardiovascular agents
Article | Year |
---|---|
Selective endothelin-A receptor inhibition after cardiac surgery: a safety and feasibility study.
Topics: Aged; Blood Pressure; Cardiopulmonary Bypass; Cardiovascular Agents; Coronary Artery Bypass; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Feasibility Studies; Humans; Isoxazoles; Male; Middle Aged; Postoperative Period; Pulmonary Artery; Thiophenes; Treatment Outcome; Vascular Resistance | 2007 |
7 other study(ies) available for thiophenes and cardiovascular agents
Article | Year |
---|---|
[Synthesis of germinal 3,3-dithienyl compounds (author's transl)].
Topics: Animals; Cardiovascular Agents; Chemical Phenomena; Chemistry; Dogs; Regional Blood Flow; Stereoisomerism; Thiophenes | 1981 |
Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging.
Topics: Animals; Atrial Natriuretic Factor; Biomarkers; Cardiovascular Agents; Disease Models, Animal; Echocardiography; Female; Heart; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Myocardium; Natriuretic Peptide, Brain; Organ Size; Peptide Fragments; Phenylpropionates; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiophenes; Troponin T | 2010 |
[Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010].
Topics: Aftercare; Anticoagulants; Cardiovascular Agents; Clopidogrel; Combined Modality Therapy; Contraindications; Electrocardiography; Emergency Medical Services; Emergency Service, Hospital; Europe; Evidence-Based Medicine; Humans; Life Style; Myocardial Infarction; Myocardial Reperfusion; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Thiophenes; Thrombolytic Therapy; Ticlopidine; Time Factors | 2010 |
Determination of the cardioactive prototype LASSBio-294 and its metabolites in dog plasma by LC-MS/MS: application for a pharmacokinetic study.
Topics: Acetates; Administration, Oral; Animals; Area Under Curve; Blood Proteins; Calibration; Cardiovascular Agents; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Chromatography, Liquid; Dogs; Hydrazones; Mass Spectrometry; Methanol; Pharmaceutical Preparations; Reproducibility of Results; Tandem Mass Spectrometry; Temperature; Thiophenes | 2011 |
Novel cardiovascular drugs in clinical trials.
Topics: Anticholesteremic Agents; Benzaldehydes; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Endothelin Receptor Antagonists; Fibrinolytic Agents; Humans; Immunologic Factors; Isoxazoles; Lipoxygenase Inhibitors; Metalloendopeptidases; Oxazolidinones; Oximes; Phospholipase A2 Inhibitors; Probucol; Pyrimidines; Quinolines; Thiophenes | 2010 |
Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury.
Topics: Animals; Apoptosis; Cardiotonic Agents; Cardiovascular Agents; Cell Survival; Diabetes Mellitus, Experimental; Heart; Humans; Male; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Oxazoles; PPAR alpha; PPAR gamma; Protective Agents; Signal Transduction; Thiophenes | 2016 |
Myocardial hypertrophy induced by high salt consumption is prevented by angiotensin II AT2 receptor agonist.
Topics: Animals; Blood Pressure; Cardiomegaly; Cardiovascular Agents; Disease Models, Animal; Fibrosis; Hypertension; Male; Myocytes, Cardiac; Rats, Wistar; Receptor, Angiotensin, Type 2; Signal Transduction; Sodium Chloride, Dietary; Sulfonamides; Thiophenes; Ventricular Remodeling; Weight Gain | 2019 |